Skip to main content
Premium Trial:

Request an Annual Quote

Most Viewed Articles on GWDN Last Week: Sep 29, 2014

NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:

1) Merck KGaA to Buy Sigma-Aldrich for $17B
2) Thermo Fisher Scientific to Develop NGS-based Oncology Companion Dx with Pfizer, GSK
3) Nanosphere Receives Deficiency Letter from Nasdaq
4) Exagen Files for $69M IPO
5) Roche Partners on Launch of Global Program for HIV Testing

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.